Development of Preladenant-Based Radiotracers for Imaging A<sub>2A</sub>R in Tumors-Reference-Cited by-同舟云学术

Development of Preladenant-Based Radiotracers for Imaging A_2AR in Tumors

Published:2024-07-22 Issue:15 Volume:67 Page:13056-13066
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zeng Xueyuan¹,Liu Hongwu¹,Huang Guolong¹,Wang Yanjie¹^ORCID,Zhou Wuhao¹,Wang Yike¹,Chen Xuedong¹,Cheng Xingxing¹,Zhuang Rongqiang¹,Li Jindian²,Fang Jianyang¹,Huang Lumei¹,Zhang Xianzhong³^ORCID,Guo Zhide¹^ORCID

Affiliation:

1. State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102, China

2. Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai 200032, China

3. Theranostics and Translational Research Center, Institute of Clinical Medicine, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &, Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China

Funder

National Natural Science Foundation of China

National High-Level Hospital Clinical Research Funding

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c01015

Reference38 articles.

1. Extracellular ATP and adenosine in tumor microenvironment: Roles in epithelial–mesenchymal transition, cell migration, and invasion

2. Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia

3. CD39/CD73/A2AR pathway and cancer immunotherapy

4. Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner

5. Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy